CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40

被引:352
作者
Yang, YP
Wilson, JM
机构
[1] WISTAR INST ANAT & BIOL,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[2] UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104
[3] UNIV PENN,MED CTR,DEPT MOL & CELLULAR ENGN,PHILADELPHIA,PA 19104
关键词
D O I
10.1126/science.273.5283.1862
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of CD40 ligand (CD40L) in the primary activation of T cells is not clear. The cellular and humoral immune responses to adenoviral vectors in a murine model of liver-directed gene transfer were studied to define the mechanisms responsible for CD40L-dependent T cell priming. CD40L-deficient mice did not develop effective cytotoxic T cells to transduced hepatocytes, and T cell-dependent B cell responses were absent. Full reconstitution of cellular and humoral immunity was achieved in CD40L-deficient mice by administration of an activating antibody to CD40 that increased expression of B7.2 on spleen cells. Wild-type mice could be made nonresponsive to vector by administration of antibodies to B7. Thus, CD40L-dependent activation of T cells occurs through signaling of CD40 in the antigen-presenting cell to enhance requisite costimulatory pathways that include B7.
引用
收藏
页码:1862 / 1864
页数:3
相关论文
共 24 条
  • [1] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME
    ALLEN, RC
    ARMITAGE, RJ
    CONLEY, ME
    ROSENBLATT, H
    JENKINS, NA
    COPELAND, NG
    BEDELL, MA
    EDELHOFF, S
    DISTECHE, CM
    SIMONEAUX, DK
    FANSLOW, WC
    BELMONT, J
    SPRIGGS, MK
    [J]. SCIENCE, 1993, 259 (5097) : 990 - 993
  • [2] THE YIN AND YANG OF T-CELL COSTIMULATION
    ALLISON, JP
    KRUMMEL, MF
    [J]. SCIENCE, 1995, 270 (5238) : 932 - 933
  • [3] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [4] CD40 ligand is required for protective cell-mediated immunity to Leishmania major
    Campbell, KA
    Ovendale, PJ
    Kennedy, MK
    Fanslow, WC
    Reed, SG
    Maliszewski, CR
    [J]. IMMUNITY, 1996, 4 (03) : 283 - 289
  • [5] CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION
    DAI, YF
    SCHWARZ, EM
    GU, DL
    ZHANG, WW
    SARVETNICK, N
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1401 - 1405
  • [6] CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM
    DISANTO, JP
    BONNEFOY, JY
    GAUCHAT, JF
    FISCHER, A
    DESAINTBASILE, G
    [J]. NATURE, 1993, 361 (6412) : 541 - 543
  • [7] IMPAIRMENT OF ANTIGEN-SPECIFIC T-CELL PRIMING IN MICE LACKING CD40 LIGAND
    GREWAL, IS
    XU, JC
    FLAVELL, RA
    [J]. NATURE, 1995, 378 (6557) : 617 - 620
  • [8] PROPERTIES OF MOUSE CD40 - CELLULAR-DISTRIBUTION OF CD40 AND B-CELL ACTIVATION BY MONOCLONAL ANTI-MOUSE CD40 ANTIBODIES
    HASBOLD, J
    JOHNSONLEGER, C
    ATKINS, CJ
    CLARK, EA
    KLAUS, GGB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1835 - 1842
  • [9] Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity
    Kamanaka, M
    Yu, P
    Yasui, T
    Yoshida, K
    Kawabe, T
    Horii, T
    Kishimoto, T
    Kikutani, H
    [J]. IMMUNITY, 1996, 4 (03) : 275 - 281
  • [10] LONG-TERM HEPATIC ADENOVIRUS-MEDIATED GENE-EXPRESSION IN MICE FOLLOWING CTLA4LG ADMINISTRATION
    KAY, MA
    HOLTERMAN, AX
    MEUSE, L
    GOWN, A
    OCHS, HD
    LINSLEY, PS
    WILSON, CB
    [J]. NATURE GENETICS, 1995, 11 (02) : 191 - 197